Navigation Links
New Topical Patent Research Reports Recently Published at MarketPublishers.com
Date:12/27/2010

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd informs that new in-demand market reports featuring drugs patent researches have been added to its catalogue "Drugs & Biotechnology."

Each of the recently published reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

New market patent research reports include:

  • Sevelamer - Comprehensive Patent Search
  • Sildenafil - Comprehensive Patent Search
  • Silodosin - Comprehensive Patent Search
  • Sorafenib - Comprehensive Patent Search
  • Sunitinib - Comprehensive Patent Search
  • Tadalafil - Comprehensive Patent Search
  • Tazobactam - Comprehensive Patent Search

  • SOURCE The Market Publishers, Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
    2. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
    3. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
    4. Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
    5. Topical erectile dysfunction therapy shows promise
    6. Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens
    7. Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
    8. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
    9. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
    10. Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks
    11. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
    (Date:2/27/2015)... DIEGO , Feb. 27, 2015  Pfenex Inc. ... the development of biosimilar therapeutics, today announced that it ... Francisco Marriott Marquis on March 2 nd at ... participate on a panel discussing the current state of ... of Biosimilars . For more information ...
    (Date:2/27/2015)... 27, 2015   PureTech , a science and ... disruptive products and technologies in the healthcare sector, announced ... CEO and Member of the Board of Directors of ... "It,s has been a pleasure to know Chris for ... will be working together more closely now," said Dr. ...
    (Date:2/26/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... and commercializes proprietary technologies and products for advanced microarray ... the fiscal first quarter ended December  31, 2014. All ... (CAD), unless otherwise stated. "During the ... our existing customers and add to our sales pipeline," ...
    Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
    ... Calif., Feb. 27 Telik, Inc.,(Nasdaq: TELK ) ... per share,for the fourth quarter ended December 31, 2007, ... per share, for the comparable period in 2006., ... costs and,expenses were $13.5 million, compared with $19.5 million ...
    ... ZARS Pharma, Inc. announced,today that Rapydan(R) ... now received marketing authorization in Sweden, the ... Czech Republic, Greece, Ireland,Norway and Portugal following ... ZARS Pharma has licensed the European sales ...
    ... Fla., Feb. 27 Imaging,Diagnostic Systems, Inc., ... laser,optical breast imaging systems, will exhibit CT ... National Interdisciplinary Breast Cancer,Conference, March 1-5, in ... at booth,#43., (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ...
    Cached Biology Technology:Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 2Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 3Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 4ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe 2ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe 3CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference 2
    (Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
    (Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
    (Date:2/5/2015)... , Jan. 28, 2015 Research and Markets ... addition of the "Global Biometrics Market (2014-2020): ... and Countries " report to their offering. ... Asia-Pacific is anticipated to overtake ... owing to increasing government spending towards IT security, ...
    Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
    ... the only ones making exciting scientific discoveries these days. ... of scientists who are reporting the first glimpse of ... helps activate certain antibiotics and anti-cancer agents so that ... ACS, weekly journal Biochemistry . The student co-authors ...
    ... College Park, MD (July 27, 2010) -- Kites have a ... and his study of electricity -- including being used to ... sensors, because they were exposed to direct sunlight, were prone ... the University of Reading in the United Kingdom have developed ...
    ... MN Current research suggests that taking morphine can ... related report by Koodie et al, "Morphine suppresses tumor ... 2010 issue of the American Journal of Pathology ... analgesics used to relieve severe pain and suffering. ...
    Cached Biology News:
    ...
    The Captivate Disposable Sample Chamber is designed for use with the Captivate magnetic yoke assembly (C-24700) and can be used with our Captivate ferrofluid conjugates (C-21473 C-21474 C-21476) or ...
    MOUSE ANTI HUMAN MOC31:AZIDE FREE...
    ... The mycobacteria in ... cells to the injection site which enhances ... Freund's Adjuvant is used for the initial ... the subsequent boosts. Antigens (preferably in saline) ...
    Biology Products: